for Jan 25, 2023
🔥Wow🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
🆕️Retrospective cohort @CIDJournal @IDpharmresearch
High Dose Cefepime Vs Carbapenems for Bacteremia Caused by Enterobacterales with Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
Similar risk of 30d mortality!
RCT? https://t.co/pafpQPxGVB pic.twitter.com/rP1k7QuIQT
In the presence of antidepressants, the Gram-negative bacteria, E. coli, can develop #AntibioticResistancehttps://t.co/W36lbDAWbq
— MicrobesInfect (@MicrobesInfect) January 25, 2023
It's flu season! This #ClinMicroRev article describes current FDA-approved influenza antivirals, viral- and host-directed antiviral approaches and the potential utility of machine learning in developing next-generation antivirals against influenza. https://t.co/lUkNW4XTSL pic.twitter.com/Neverht1BP
— ASM (@ASMicrobiology) January 25, 2023
Impact of Vaccination on Cost and Course of Hospitalization Associated with #COVID19 Infection #vaccines
— ASHE Journal (@ASHE_Journal) January 25, 2023
📄 https://t.co/5rqwyjQTnl pic.twitter.com/Qw3bMAIIrq
New research in @mbiojournal shows that E. coli-derived extracellular vesicles (EVs) lead host cells to release EVs that enhance inflammatory responses, thus providing a novel example whereby bacterial EVs transduce biological signals to mammalian EVs. https://t.co/hb8gGphfU2 pic.twitter.com/PMLfTIhnif
— ASM (@ASMicrobiology) January 25, 2023
🆕️⚡️ @OFIDJournal
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
Real-world use of bezlotoxumab and fecal microbiota transplantation for the treatment of Clostridioides difficile infection #IDTwitter https://t.co/QLm5YZisyR pic.twitter.com/hQOdVu2P6z
Antivaxxers love surveys. This time @BioMedCentral Infectious Diseases somehow published a truly awful one by an economist named Mark Skidmore that claims that #CovidVaccines have killed nearly 300,000 people. https://t.co/dKLTJ3DTuQ
— David Gorski, MD, PhD (@gorskon) January 25, 2023
How antidepressants help bacteria resist antibiotics https://t.co/sWb4rtKd7i
— Stop Superbugs (@TheUrgentNeed) January 25, 2023
Antibiotic resistance is a public health crisis and we all need to do our part to address it. read my letter in @washingtonpost https://t.co/fVvpEOOYr8
— Carlos del Rio (@CarlosdelRio7) January 25, 2023
Very excited this week for our midwinter event with career updates + mock study sections with our amazing 2022 cohort of @UCSanDiego Raising Advancement and Parity for Infectious Diseases Researchers (RAPID) junior faculty scholars from across the US (1/2)https://t.co/UoRqwVdgZx pic.twitter.com/DbkHEUxPuP
— ᐯIᑕTOᖇ ᑎIᘔET (@victornizet) January 25, 2023
Challenging Allergy - Drug Hypersensitivity Symposium #DHS2023
— Jason Trubiano 🆔 (@TrubianoJason) January 25, 2023
May 19th - 20th 2023 @TheDohertyInst
Registrations open Monday 30th of Jan
In-person and virtual options so all interested in #drugallergy #antibioticallergy can attend!https://t.co/3yWx50odkc
"That increase [in #antibiotic-resistant infections in the early days of #COVID19] we saw was due, in part, to the fact these stewardship and safety programs weren't able to function at the level they used to pre-pandemic," @pewhealth’s David Hyun, MD. https://t.co/G7JWYzm9DJ
— Save Antibiotics (@saveantibiotics) January 25, 2023
It's here! We're looking for a Centre Manager to help establish and run the ARC Industrial Transformation Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (ARC CEA-StAR).....https://t.co/3JWDgwnutT #antimicrobialresistance
— Mark Blaskovich (@mark_blaskovich) January 25, 2023
SA is an uncommon cause of community-acquired bacterial meningitis
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
Community-acquired S.aureus meningitis is a severe disease with a high case fatality rate,occurring mainly n pts with concomitant endocarditis or spondylodiscitis #wikiguidlines #IDTwitter https://t.co/Z5s65SDhcI
"Once antibiotic resistance develops in one community, it can easily spread to other locations and establish itself in healthcare facilities” https://t.co/2Kmm8zZ3Tg
— Amesh Adalja (@AmeshAA) January 25, 2023
FDA panel recommends rezafungin as new #Candida treatment
— CIDRAP (@CIDRAP) January 25, 2023
An FDA committee recommends approval of rezafungin for the treatment of candidemia and invasive candidiasis in adultshttps://t.co/4FMZEVw3Oi#AMR #Fungalinfection #AntimicrobialStewardship
Very high levels of protection against severe disease with hybrid immunity and it lasts much more than 12 months.
— Peter Collignon (@CollignonPeter) January 25, 2023
The effectiveness of hybrid immunity against hospital admission or severe disease was 97·4% (95% CI 91·4–99·2) at 12 months with primary vax https://t.co/IDYJ804RWX
“ID is one of the few specialties, if not the only specialty, where you make less after training than before,” says IDSA president @CarlosdelRio7 about the complex issues leading to the ID doc shortage in this @FoxNews article.
— IDSA (@IDSAInfo) January 25, 2023
Learn more: https://t.co/fUpYM7vIrc
“This is a call to action to stay vigilant about #antimicrobial resistance threats,” @MDHealthDept’s Dr. Katherine Hsu warns following the discovery of a novel strain of #gonorrhea in the U.S. https://t.co/DqH4WFOG4o
— Save Antibiotics (@saveantibiotics) January 25, 2023
Groups sue FDA over antibiotic misuse in livestock
— CIDRAP (@CIDRAP) January 25, 2023
The lawsuit says the agency failed to address concerns that the use of medically important antibiotics for disease prevention in livestock and poultry poses a threat to human healthhttps://t.co/4VZvFYpSVR#AMR pic.twitter.com/xbvfKUm60q
#BYCOVID is holding an 🦠 Infecious disease toolkit Contetnathon in March!
— BY-COVID Project (@BYCOVID_eu) January 25, 2023
Join the discussion with 🔧 toolkit editors and other content contributors to help enhance infectious diseases outbreak preparedness.
🔗 Register now: https://t.co/FWwCdA7QUD#openscience #bioinformatics pic.twitter.com/H0oe6YMlpP
Comparison of the efficacy and safety of standard- and high-dose daptomycin: a systematic review and meta-analysis https://t.co/Tf76ioFfsO
— Tristan Timbrook (@TristanTimbrook) January 25, 2023
Amazing timing, because a study was just published in BMC Infectious Diseases: They found that respondents who knew others who experienced a adverse event after COVID vaccination (21.6%) were *much* less likely to be vaccinated, and it was very common. https://t.co/qziP1qJSJj
— Josh Guetzkow (@joshg99) January 25, 2023
In their lawsuit, @enviRN, @Talk_With_FACT, @NRDC & @Public_Citizen "claim FDA violated the Administrative Procedure Act when it denied a 2016 petition by the groups to ban use of medically impt antibiotics for disease prevention in livestock and poultry."https://t.co/i8pHLi5WLI
— Chris Hendel (@chrishendel) January 25, 2023
A series of fascinating heat maps showing the number of cases of several infectious diseases before and after their vaccines were introduced https://t.co/iOjuLRqut1
— Stefan Marciniak (@Prof_Marciniak) January 25, 2023
Great to see that our paper was picked as a Microbiology and Infectious Diseases highlight by the editors at Nature Communications: https://t.co/VutKV4lR15 https://t.co/Kxyglc2PK0
— Marc Henrion (@lemoncul) January 25, 2023
Bae et al found that rifampicin-resistant MRSA bacteraemia isolates were more likely to have MDR & higher vancomycin MIC compared with rifampicin-susceptible MRSA. Rifampicin resistance was significantly associated with 90-day recurrence:https://t.co/JEaa7sLobA#JACNews
— BSAC (@BSACandJAC) January 25, 2023
Early detection of infectious diseases in chickens and developing regional influenza vaccines for pigs are among 28 innovative livestock and forage research projects at #USask to be awarded a total of $5.2 million in new funding. #USaskResearchhttps://t.co/KonJ5BbjS7
— U of Saskatchewan (@usask) January 25, 2023
RCT | 2 days of postoperative antibiotics is noninferior to 5 days in patients with complex appendicitis – via @TheLancethttps://t.co/ZOdh59F1cf
— LinksMedicus.com (@Links_Medicus) January 25, 2023
Commentary: https://t.co/Dc39rMhgx0
🔬The rapid expansion of Timor-Leste’s laboratory abilities during the COVID-19 pandemic has better prepared the country to respond to future infectious disease outbreaks, say @MenziesResearch @UniMelb @TheDohertyInst and @ANUmedia https://t.co/QZ119N3m4d pic.twitter.com/xFdaNVfI4x
— Au Science Media Ctr (@AusSMC) January 25, 2023
🔥GREAT🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
Bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2–4 monovalent vaccine doses@CDCMMWR #IDTwitter https://t.co/Ln788PbmYG
Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience - International Journal of Infectious Diseases https://t.co/eDx5UZ1xwC
— Megan Morales, MD (@TIDinRVA) January 25, 2023
PRO/AMR> Antimicrobial stewardship (14): India (Kerala), strategic action plan https://t.co/QK3pEFla6z
— ProMED (@ProMED_mail) January 25, 2023
Global flu activity declines further amid rising H1N1 rates
— CIDRAP (@CIDRAP) January 25, 2023
In North America, #flu levels are now at or below levels typically seen at this time of the yearhttps://t.co/7wLimy9dKx#Influenza
Groups sue FDA over antibiotic misuse in livestock https://t.co/awr8dGyvvn
— Crawford Kilian (@Crof) January 25, 2023
World Health Organization – @WHO – announces effort to speed development of #TB #vaccines
— APPRISE (@APPRISE_CRE) January 25, 2023
Study estimates a TB vaccine that is 75% effective could avert up to 110 million new TB cases and 12.3 million deaths over 25 years#tuberculosis https://t.co/xYnqwMAMH2
'Trends in pediatric community-onset Staphylococcus aureus antibiotic susceptibilities over a five-year period in a multihospital health system' - an Open Access article by @ASHE_Journal #Staphylococcusaureus #OpenAccess #Oxacillinhttps://t.co/4Y2NLJbyZt
— Cambridge Medicine and Health Sciences (@CUP_med_health) January 25, 2023
interesting to read perspective of #physicians who do not support the PASTEUR act for #antibiotics Why the PASTEUR Act is no cure for antimicrobial resistance https://t.co/jgCrE8MAWQ@JohnRex_NewAbx @CARB_X @CarlosdelRio7
— Debbie Goff (@idpharmd) January 25, 2023
Do I tell the urgent care that they prescribed me an inappropriate duration of antibiotics and that they need to improve their antimicrobial stewardship?
— Heather (@jewcy22) January 25, 2023
Vax very good for prolonged protection again severe disease but much less so for mild disease and transmission.
— Peter Collignon (@CollignonPeter) January 25, 2023
“All estimates of protection waned within months against reinfection but remained high and sustained for hospital admission or severe disease” https://t.co/IDYJ804RWX
Register now for the joint BSAC and @gardp_amr
— BSAC (@BSACandJAC) January 25, 2023
virtual ACC2023 conference in collaboration with @AfricaCDC and @ReActAfrica_RAN
View the programme and book your FREE place here https://t.co/nJYEQfhKNO pic.twitter.com/KYItYLDiA0
Postdoc (London, UK)
— IDDjobs: infectious disease dynamics jobs (@IDDjobs) January 25, 2023
Climate change impact on infectious diseases
at @vaccineimpact @MRC_Outbreak @Grantham_IC
More details: https://t.co/qOuU4ZnYj1
“The end of the #antibiotic era—when a doctor has nothing left to treat an infection—is too horrible to contemplate.” –@washingtonpost editorial board https://t.co/36RiRTjPXT
— Save Antibiotics (@saveantibiotics) January 25, 2023
We all know handwashing is the first line of defence against infection. But what if you don't have access to clean water? We're raising funds to help build handwashing facilities for 600 families in Kenya. Even a small donation can change lives: https://t.co/zEqoWwYP0Q pic.twitter.com/QXez8UYpmB
— Stop Superbugs (@TheUrgentNeed) January 25, 2023
#IDTwitter @ASHE_Journal From our pediatric colleagues, the evolving epidemiology of community onset of Staphylococcus aureus infections...in ASHE https://t.co/L9VVzWdJ26
— Gonzalo Bearman (@gonzalobearman) January 25, 2023
These are stories because insurance companies & Pharma run health care:
— Tim Lahey, MD, MMSc (@TimLaheyMD) January 25, 2023
Who gets expensive new therapies? https://t.co/eJ2vdQqdMW
Moderna to charge >$100/dose of publicly-funded vaccines https://t.co/0ruRclPAU2
More hospital layoffs https://t.co/8toxQ5jlPi pic.twitter.com/zDV2C6m4a8
#IDTwitter @ASHE_Journal We need a reliable measure of antibiotic use for respiratory conditions...this is a step in the right direction, published in....ASHE.. https://t.co/3lMMTpigEl
— Gonzalo Bearman (@gonzalobearman) January 25, 2023
The Vaccines For Children program has helped prevent diseases and save lives … avoiding more than 1 million deaths since 1994! Learn more: https://t.co/w9XeZ7gJSj pic.twitter.com/eWeapcaplr
— NFID (@NFIDVaccines) January 25, 2023
Microbiology plays important role in medical devices such as #fluorescent fusion in detection of #pathogens in tissue sample.
— Symbiosis Online (@symbiosisonline) January 25, 2023
Visit: https://t.co/9uFHTO4u2e#microbiology #infection #infectiousdiseases #disease #fermentation #cosmetics #fluorescentfusion #lifesciences pic.twitter.com/IEHSp7b0wh
Not sure if it's #flu? Think F.A.C.T.S.
— NFID (@NFIDVaccines) January 25, 2023
If you have: Fever, Aches, Chills, Tiredness, with Sudden Onset … you might have flu and should speak to a healthcare professional as soon as possible.#GetVaccinated to help #FightFlu and learn more at https://t.co/5OlDg1uH0Z pic.twitter.com/LsRMZJVtQ6
Our paper on social network and respiratory tract infections has been published!
— Gillian Murphy (@stumblleine) January 25, 2023
Thanks so much to my supervisors @AmaiaCalderon @GiorgiBeridze_ @DLVetrano#infectiousdiseases #socialnetwork #Stockholm #aging https://t.co/8UCcargvxT
The concept of dose optimisation strategies, such as MIPD interventions,remains of great interest, albeit currently not well supported. Recent clinical trial evidence shows no favourable impact & is hampered by low rates of PD target attainment #DOLPHINhttps://t.co/arWYnKX3FR
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
Created by Cameron Forbes. Last updated January 31, 2023 at 05:16 EST.